Prostate Cancer study: JANX014
Official title Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov ID: NCT07545811
What this study is testing
What is JANX014?
JANX014 is an investigational biological medicine being studied for metastatic castration‑resistant prostate cancer.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether JANX014 is safe and how it behaves in the body for men with advanced prostate cancer.
- Who it's for
- You may be able to join if you are an adult man with metastatic castration‑resistant prostate cancer.
- What's involved
- You will receive JANX014 and have blood tests and scans to see how the drug works and if it causes side effects.
- Time commitment
- The study lasts about 6 months and includes several clinic visits and tests during that time.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Male ≥18 years of age at the time of signing informed consent
- Histologically or cytologically confirmed adenocarcinoma of the prostate
- For Dose Escalation: Having mCRPC that progressed after at least one novel anti-androgen therapy and at least one taxane containing regimen.
- Adequate organ function
- For Dose Expansion Part: Have received ≤ 2 anti-androgen therapies in either the HSPC or CRPC setting and no more than 1 prior taxane regimen in the...
You likely can't join if
- Prior solid organ transplant
- Prior treatment with any CAR-T cell therapy, approved or investigational T-cell engager therapy, and prior receipt of radioligand therapy
- Clinically significant cardiovascular disease
The study team makes the final eligibility decision.
Where it is enrolling
- La Jolla, California, United States
- St Louis, Missouri, United States
- Charleston, South Carolina, United States
- Greenville, South Carolina, United States
- Nashville, Tennessee, United States
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at La Jolla, California, United States; St Louis, Missouri, United States; Charleston, South Carolina, United States; Greenville, South Carolina, United States; Nashville, Tennessee, United States; Dallas, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.